169 related articles for article (PubMed ID: 16526555)
61. Physicochemical properties and in vitro toxicity of cationic liposome cDNA complexes.
Schreier H; Gagné L; Bock T; Erdos GW; Druzgala P; Conary JT; Müller BW
Pharm Acta Helv; 1997 Sep; 72(4):215-23. PubMed ID: 9372644
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of the high-pressure extrusion technique as a method for sizing plasmid DNA-containing cationic liposomes.
Carstens MG; van der Maaden K; van der Velden D; Ottenhoff TH; Melief CJ; Ossendorp F; Bouwstra JA; Jiskoot W
J Liposome Res; 2011 Dec; 21(4):286-95. PubMed ID: 21417671
[TBL] [Abstract][Full Text] [Related]
63. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.
Mahato RI; Kawabata K; Nomura T; Takakura Y; Hashida M
J Pharm Sci; 1995 Nov; 84(11):1267-71. PubMed ID: 8587040
[TBL] [Abstract][Full Text] [Related]
64. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
65. Chemical hydrolysis of DOTAP and DOPE in a liposomal environment.
Vernooij EA; Kettenes-van den Bosch JJ; Underberg WJ; Crommelin DJ
J Control Release; 2002 Feb; 79(1-3):299-303. PubMed ID: 11853940
[TBL] [Abstract][Full Text] [Related]
66. Lipid-Coated, pH-Sensitive Magnesium Phosphate Particles for Intracellular Protein Delivery.
Fang Y; Vadlamudi M; Huang Y; Guo X
Pharm Res; 2019 Apr; 36(6):81. PubMed ID: 30976936
[TBL] [Abstract][Full Text] [Related]
67. Cationic Nanoliposomes Are Efficiently Taken up by Alveolar Macrophages but Have Little Access to Dendritic Cells and Interstitial Macrophages in the Normal and CpG-Stimulated Lungs.
Vanbever R; Loira-Pastoriza C; Dauguet N; Hérin C; Ibouraadaten S; Vanvarenberg K; Ucakar B; Tyteca D; Huaux F
Mol Pharm; 2019 May; 16(5):2048-2059. PubMed ID: 30965005
[TBL] [Abstract][Full Text] [Related]
68. Intracellular trafficking mechanism of cationic phospholipids including cationic liposomes in HeLa cells.
Un K; Sakai-Kato K; Goda Y
Pharmazie; 2014 Jul; 69(7):525-31. PubMed ID: 25073398
[TBL] [Abstract][Full Text] [Related]
69. Pulmonary gene delivery of hybrid vector, lipopolyplex containing N-lauroylsarcosine, via the systemic route.
Kurosaki T; Kishikawa R; Matsumoto M; Kodama Y; Hamamoto T; To H; Niidome T; Takayama K; Kitahara T; Sasaki H
J Control Release; 2009 Jun; 136(3):213-9. PubMed ID: 19233236
[TBL] [Abstract][Full Text] [Related]
70. Cage-like complexes formed by DOTAP, Quil-A and cholesterol.
Lendemans DG; Egert AM; Hook S; Rades T
Int J Pharm; 2007 Mar; 332(1-2):192-5. PubMed ID: 17049770
[TBL] [Abstract][Full Text] [Related]
71. Persistent transgene expression following intravenous administration of a liposomal complex: role of interleukin-10-mediated immune suppression.
Ito I; Saeki T; Mohuiddin I; Saito Y; Branch CD; Vaporciyan A; Roth JA; Ramesh R
Mol Ther; 2004 Mar; 9(3):318-27. PubMed ID: 15006598
[TBL] [Abstract][Full Text] [Related]
72. Associating oligonucleotides with positively charged liposomes.
Jurkiewicz P; Okruszek A; Hof M; Langner M
Cell Mol Biol Lett; 2003; 8(1):77-84. PubMed ID: 12655360
[TBL] [Abstract][Full Text] [Related]
73. [Preparation and physicochemical properties of vinorelbine liposomes].
Li XT; Cheng L; Jia TZ
Zhong Yao Cai; 2011 Jan; 34(1):119-22. PubMed ID: 21818978
[TBL] [Abstract][Full Text] [Related]
74. Role of cholesterol, DOTAP, and DPPC in prostasome/spermatozoa interaction and fusion.
Palmerini CA; Cametti C; Sennato S; Gaudino D; Carlini E; Bordi F; Arienti G
J Membr Biol; 2006; 211(3):185-90. PubMed ID: 17091211
[TBL] [Abstract][Full Text] [Related]
75. In vivo NIRF imaging of tumor targetability of nanosized liposomes in tumor-bearing mice.
Lee S; Lee SY; Park S; Ryu JH; Na JH; Koo H; Lee KE; Jeon H; Kwon IC; Kim K; Jeong SY
Macromol Biosci; 2012 Jun; 12(6):849-56. PubMed ID: 22535787
[TBL] [Abstract][Full Text] [Related]
76. Liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells.
Grace VMB; Wilson DD; Guruvayoorappan C; Danisha JP; Bonati L
IET Nanobiotechnol; 2021 Jun; 15(4):380-390. PubMed ID: 34694713
[TBL] [Abstract][Full Text] [Related]
77. Safe and effective delivery of small interfering RNA with polymer- and liposomes-based complexes.
Kodama Y; Harauchi S; Kawanabe S; Ichikawa N; Nakagawa H; Muro T; Higuchi N; Nakamura T; Kitahara T; Sasaki H
Biol Pharm Bull; 2013; 36(6):995-1001. PubMed ID: 23727920
[TBL] [Abstract][Full Text] [Related]
78. Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration.
Ito I; Began G; Mohiuddin I; Saeki T; Saito Y; Branch CD; Vaporciyan A; Stephens LC; Yen N; Roth JA; Ramesh R
Mol Ther; 2003 Mar; 7(3):409-18. PubMed ID: 12668137
[TBL] [Abstract][Full Text] [Related]
79. Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s.
Romberg B; Oussoren C; Snel CJ; Hennink WE; Storm G
Pharm Res; 2007 Dec; 24(12):2394-401. PubMed ID: 17674159
[TBL] [Abstract][Full Text] [Related]
80. A novel method for measuring rigidity of submicron-size liposomes with atomic force microscopy.
Nakano K; Tozuka Y; Yamamoto H; Kawashima Y; Takeuchi H
Int J Pharm; 2008 May; 355(1-2):203-9. PubMed ID: 18280678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
